Baseline Characteristic of patients with acute coronary syndrome |
||||
|
2018 |
2019 |
2020 |
P value |
Age |
66.4±12.8 |
66.4±12.2 |
68.1±12.1 |
0.57 |
Age > 75 years, n (%) |
28 (27.7) |
37 (28.4) |
30 (34.9) |
0.52 |
Male sex, n (%) |
73 (72.3) |
95 (73.1) |
59 (68.6) |
0.77 |
BMI |
29.2±5.7 |
28.0±4.5 |
28.0±4.6 |
0.26 |
Current Smoking, n (%) |
50 (49.5) |
65 (50.0) |
44 (51.2) |
0.98 |
Hypertension, n (%) |
73 (72.3) |
90 (69.2) |
61 (70.9) |
0.93 |
Hypercholesterolemia, n (%) |
45 (44.6) |
57 (43.8) |
20 (23.3) |
0.002 |
Diabetes mellitus, n (%) |
21 (21.0) |
31 (23.8) |
19 (22.1) |
0.85 |
Peripheral artery disease, n (%) |
13 (12.9) |
5 (3.8) |
7 (8.1) |
0.04 |
Chronic renal insufficiency |
|
|
|
|
Previous myocardial infarction, n (%) |
12 (11.9) |
18 (13.8) |
10 (11.6) |
0.85 |
Previous PCI, n (%) |
16 (15.8) |
29 (22.3) |
14 (16.3) |
0.37 |
Previous coronary artery bypass grafting, n (%) |
3 (3.0) |
5 (3.8) |
6 (6.7) |
0.42 |
Troponin I |
557 (62 - 7050) |
423 (54 - 4150) |
325 (75 - 1497) |
0.21 |
Creatinine |
1.0±0.5 |
1.0±0.3 |
1.0±0.4 |
0.65 |
Creatinine clearance |
77±24 |
78±23 |
77±24 |
0.93 |
Low-density lipoprotein cholesterol |
133±44 |
131±48 |
183±53 |
0.63 |
Hemoglobin |
13.6±1.9 |
13.6±1.9 |
13.9±1.8 |
0.41 |
Hematocrit |
41±5.4 |
40.0±5.5 |
41.5±5.2 |
0.10 |
ST-segment elevation myocardial infarction, n (%) |
58 (57.4) |
66 (50.8) |
42 (48.8) |
0.50 |
Non-ST- segment elevation myocardial infarction, n (%) |
43 (42.6) |
63 (48.5) |
43 (50.0) |
0.50 |
GRACE-Score |
151±46 |
147±40 |
142±44 |
0.37 |
GRACE-score < 109 |
20 (19.8) |
13 (10.0) |
14 (16.3) |
0.11 |
GRACE-score 109 - 149 |
31 (30.7) |
64 (49.2) |
43 (50.0) |
0.06 |
GRACE-score >149 |
50 (49.5) |
52 (40.0) |
29 (33.7) |
0.09 |
Number of affected Vessels, n (%) |
|
|
|
|
1 |
33 (32.7) |
46 (35.4) |
27 (31.4) |
0.73 |
2 |
38 (37.6) |
48 (36.9) |
30 (34.9) |
0.89 |
3 |
30 (29.7) |
32 (24.6) |
29 (33.7) |
0.42 |
Left ventricular ejection fraction |
50±11 |
51±12 |
48±11 |
0.17 |
Time from Symptom onset to index PCI, N (%) |
|
|
|
|
=6 |
70 (69.3) |
93 (71.5) |
48 (55.8) |
0.04 |
>6 |
31 (30.7) |
35 (28.5) |
37 (44.2) |
0.04 |
Table. 1 Baseline Characteristics
Tab. 2 Procedural characteristic of patients with acute coronary syndrome |
||||
|
2018 |
2019 |
2020 |
P-value |
Arterial Access, n (%) |
|
|
|
|
femoral |
99 (98.0) |
81 (62.3) |
39 (45.3) |
<0.001 |
radial |
2 (2.0) |
46 (35.4) |
47 (54.7) |
<0.001 |
Stent in culprit lesion |
98 |
127 |
85 |
0.93 |
Length of procedure |
63±30 |
56±25 |
63±29 |
0.14 |
The total dose of contrast material |
190±67 |
1778±67 |
191±67 |
0.16 |
The total duration of fluoroscopy |
11.3±8.6 |
11.0±8.4 |
11.9±6.9 |
0.74 |
Mortality |
|
|
|
|
In-hospital mortality, n (%) |
10 (9.9) |
8 (6.2) |
3 (3.5) |
0.22 |
Medication at discharge, n (%) |
|
|
|
|
Aspirin |
97 (96.0) |
124 (95.4) |
84 (97.7) |
0.92 |
Ticagrelor |
83 (82.2) |
103 (79.3) |
74 (86.0) |
0.50 |
Prasugrel |
1 (1.0) |
4 (3.1) |
2 (2.3) |
0.56 |
Clopidogrel |
12 (11.9) |
19 (14.6) |
8 (9.3) |
0.52 |
Beta-blocker |
88 (87.1) |
104 (80.0) |
70 (81.4) |
0.21 |
Angiotensin-converting enzyme inhibitor |
68 (67.3) |
88 (67.7) |
57 (66.3) |
0.94 |
Angiotensin-receptor blocker |
68 (67.3) |
88 (67.7) |
57 (66.3) |
0.94 |
Statin |
93 (92.1) |
119 (91.5) |
82 (95.3) |
0.65 |
Table. 2 Procedural characteristics
Tables at a glance